Page 5 - manuscript_ijb05589
P. 5

1. Introduction


               Bioprinting involves the deposition of cells and biomaterials to create functional tissues and organ
                       1
               models   . It emerged from the broader field of additive manufacturing, which gained momentum
               in the 1980s. Over time, various bioprinting technologies—such as inkjet, extrusion, and light-
               based printing—have been developed to address specific needs in printing resolution, speed, and

                            2
               cell viability   . Compared to traditional 2D cell cultures, bioprinting enables the fabrication of 3D
                                                                                        3
               tissue models that offer more physiologically relevant data for drug testing   and may help reduce
                                                     4,5
               the reliance on animal experimentation  . Additionally, bioprinting holds significant promise for
               advancing regenerative medicine by enabling the creation of patient-specific tissue constructs and
                                                                            6
               reducing dependence on conventional transplantation methods  .

               Bioprinting is increasingly focused on directly depositing bioinks onto patient tissues, enabling

               rapid, on-site clinical interventions  7-10 . To support these in situ applications, portable and versatile
               bioprinting  systems  are  needed  to  navigate  the  human  body—something  conventional,  bulky

               benchtop  bioprinters  cannot  achieve.  Notably,  laser-based  bioprinters 11,12   reported  for  in-situ
               applications  have  been  limited  to  stationary  systems  without  maneuverability.  Conversely,

               handheld bioprinters and robotic arms equipped with extrusion-based depositors have been used
               to attain the maneuverability required for more complex in situ printing applications  9,13,14 .


               Achieving  reliable  in  situ  bioprinting  requires  the  printing  head  to  adapt  to  physiological
                                                                                                           15
               movements, as the body may still move under anesthesia due to breathing or involuntary motions .
               This is critical for maintaining printing resolution and preventing tissue injury. Early in situ tissue

               engineering efforts struggled to maintain print fidelity under dynamic conditions, resulting in low-
               quality constructs  16,17 . However, with advances in sensor technologies and robotic control, motion

               compensation has been explored as a solution. By integrating real-time motion compensation,

               bioprinters can eventually adapt to patient movements, ensuring consistent high-quality prints.
               Recent studies demonstrate that robotic systems with image-based motion compensation can be

               used to counteract simulated physiological movements  14,18 .

                                                                                                     19
               Among bioprinting techniques, drop-on-demand (DoD) methods—such as inkjet printing   , laser-
                                                                                     25
               induced forward transfer (LIFT)  20-24 , and laser-induced flow focusing   —are particularly well
               suited for applications requiring non-contact biomaterial deposition. Recently, our lab introduced
                                                                      26
               a DoD method termed laser-induced side transfer (LIST)   for printing low- to moderate-viscosity
                                                              4
   1   2   3   4   5   6   7   8   9   10